Sagent Names EVP

From DCAT Value Chain Insights (VCI)

By People On The Move posted 03-02-2016 09:33


Sagent Pharmaceuticals, Inc has named Frank Harmon as executive vice president, global operations. In this newly created role, Mr. Harmon will oversee Sagent's global operations, including product development, R&D, manufacturing, supply chain, regulatory and global alliance management, with oversight support of quality assurance. Mr. Harmon will report directly to Allan Oberman, Sagent's chief executive officer.

Mr. Harmon has close to 40 years of pharmaceutical operations experience with companies,including Fresenius Kabi, Cardinal Health, and Aventis-Behring (formerly Centeon LLC). Most recently, he served as vice president, operations of Nesher Pharmaceuticals, a wholly owned subsidiary of Zydus Pharmaceuticals, where he was responsible for all manufacturing and contract packaging operations for generic solid dose and oral liquid products. Prior to joining Nesher, Mr. Harmon served as chief operating officer and executive vice president of Fresenius Kabi USA, where he was responsible for managing a global network of parenteral manufacturing facilities and its global supply chain including supply from some of Sagent's current partners.

Source: Sagent Pharmaceuticals


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription